148 related articles for article (PubMed ID: 34318658)
1. Near-Infrared Radiation-Assisted Drug Delivery Nanoplatform to Realize Blood-Brain Barrier Crossing and Protection for Parkinsonian Therapy.
Liu Y; Hong H; Xue J; Luo J; Liu Q; Chen X; Pan Y; Zhou J; Liu Z; Chen T
ACS Appl Mater Interfaces; 2021 Aug; 13(31):37746-37760. PubMed ID: 34318658
[TBL] [Abstract][Full Text] [Related]
2. ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90.
Pan W; Cui B; Wang K; Shi M; Lu F; Li N; Tang B
Theranostics; 2021; 11(16):7869-7878. PubMed ID: 34335969
[No Abstract] [Full Text] [Related]
3. A Selenium Nanocomposite Protects the Mouse Brain from Oxidative Injury Following Intracerebral Hemorrhage.
Yang Y; Deng G; Wang P; Lv G; Mao R; Sun Y; Wang B; Liu X; Bian L; Zhou D
Int J Nanomedicine; 2021; 16():775-788. PubMed ID: 33574665
[TBL] [Abstract][Full Text] [Related]
4. α-Arbutin Protects Against Parkinson's Disease-Associated Mitochondrial Dysfunction In Vitro and In Vivo.
Ding Y; Kong D; Zhou T; Yang ND; Xin C; Xu J; Wang Q; Zhang H; Wu Q; Lu X; Lim K; Ma B; Zhang C; Li L; Huang W
Neuromolecular Med; 2020 Mar; 22(1):56-67. PubMed ID: 31401719
[TBL] [Abstract][Full Text] [Related]
5. Plasmonic MoO
Odda AH; Xu Y; Lin J; Wang G; Ullah N; Zeb A; Liang K; Wen LP; Xu AW
J Mater Chem B; 2019 Mar; 7(12):2032-2042. PubMed ID: 32254807
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Lipophilic Metalloporphyrins Modifies Disease Outcomes in a Rat Model of Parkinsonism.
Liang LP; Fulton R; Bradshaw-Pierce EL; Pearson-Smith J; Day BJ; Patel M
J Pharmacol Exp Ther; 2021 Apr; 377(1):1-10. PubMed ID: 33500265
[TBL] [Abstract][Full Text] [Related]
7. High Biocompatible ZIF-8 Coated by ZrO
Su L; Wu Q; Tan L; Huang Z; Fu C; Ren X; Xia N; Chen Z; Ma X; Lan X; Zhang Q; Meng X
ACS Appl Mater Interfaces; 2019 Mar; 11(11):10520-10531. PubMed ID: 30801175
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cytomembrane-Cloaked Prussian Blue Nanoparticles Enhance the Efficacy of Mild-Temperature Photothermal Therapy by Disrupting Mitochondrial Functions of Cancer Cells.
Wang P; Kankala RK; Chen B; Zhang Y; Zhu M; Li X; Long R; Yang D; Krastev R; Wang S; Xiong X; Liu Y
ACS Appl Mater Interfaces; 2021 Aug; 13(31):37563-37577. PubMed ID: 34338525
[TBL] [Abstract][Full Text] [Related]
9. Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.
Kundu P; Das M; Tripathy K; Sahoo SK
ACS Chem Neurosci; 2016 Dec; 7(12):1658-1670. PubMed ID: 27642670
[TBL] [Abstract][Full Text] [Related]
10. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
11. Quercetin Attenuates Manganese-Induced Neuroinflammation by Alleviating Oxidative Stress through Regulation of Apoptosis, iNOS/NF-κB and HO-1/Nrf2 Pathways.
Bahar E; Kim JY; Yoon H
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914791
[TBL] [Abstract][Full Text] [Related]
12. NIR-II-Activated Yolk-Shell Nanostructures as an Intelligent Platform for Parkinsonian Therapy.
Liu Y; Zhu D; Luo J; Chen X; Gao L; Liu W; Chen T
ACS Appl Bio Mater; 2020 Oct; 3(10):6876-6887. PubMed ID: 35019349
[TBL] [Abstract][Full Text] [Related]
13. Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models.
Wang WW; Han R; He HJ; Li J; Chen SY; Gu Y; Xie C
Aging (Albany NY); 2021 Apr; 13(8):11738-11751. PubMed ID: 33878030
[TBL] [Abstract][Full Text] [Related]
14. Highly bioactive zeolitic imidazolate framework-8-capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke.
He L; Huang G; Liu H; Sang C; Liu X; Chen T
Sci Adv; 2020 Mar; 6(12):eaay9751. PubMed ID: 32206718
[TBL] [Abstract][Full Text] [Related]
15. Controllable synthesis of rare earth (Gd
Xu M; Chi B; Han Z; He Y; Tian F; Xu Z; Li L; Wang J
Dalton Trans; 2020 Sep; 49(35):12327-12337. PubMed ID: 32844843
[TBL] [Abstract][Full Text] [Related]
16. Recent advancement of imidazolate framework (ZIF-8) based nanoformulations for synergistic tumor therapy.
Gao L; Chen Q; Gong T; Liu J; Li C
Nanoscale; 2019 Nov; 11(44):21030-21045. PubMed ID: 31674617
[TBL] [Abstract][Full Text] [Related]
17. Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease.
Wu DM; Han XR; Wen X; Wang S; Fan SH; Zhuang J; Wang YJ; Zhang ZF; Li MQ; Hu B; Shan Q; Sun CH; Lu J; Zheng YL
Cell Physiol Biochem; 2018; 46(5):1793-1806. PubMed ID: 29705802
[TBL] [Abstract][Full Text] [Related]
18. Triphenyl phosphonium coated nano-quercetin for oral delivery: Neuroprotective effects in attenuating age related global moderate cerebral ischemia reperfusion injury in rats.
Ghosh S; Sarkar S; Choudhury ST; Ghosh T; Das N
Nanomedicine; 2017 Nov; 13(8):2439-2450. PubMed ID: 28822845
[TBL] [Abstract][Full Text] [Related]
19. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
Tseng YT; Chang FR; Lo YC
Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
[TBL] [Abstract][Full Text] [Related]
20. NIR-Assisted MgO-Based Polydopamine Nanoparticles for Targeted Treatment of Parkinson's Disease through the Blood-Brain Barrier.
Gao Y; Cheng Y; Chen J; Lin D; Liu C; Zhang LK; Yin L; Yang R; Guan YQ
Adv Healthc Mater; 2022 Dec; 11(23):e2201655. PubMed ID: 36153843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
